This makes two in the works of approved clinical trials. Patiently awaiting FDA approval for prescribed treatment. https://www.biospace.com/article/american-cryostem-announces-fda-approval-of-ind-to-commence-phase-i-clinical-trial-for-long-covid-post-acute-sequelae-of-sars-cov-2-pasc-/?s=89